Skip to main content

Anterior Urethral Stricture, Male

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Laborie
LaborieNH - Portsmouth
1 program
Optilume Registry for Treatment of Stricture of the Anterior UrethraN/A1 trial
Active Trials
NCT05479422Active Not Recruiting150Est. Aug 2029

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
2029
LaborieOptilume Registry for Treatment of Stricture of the Anterior Urethra

Clinical Trials (1)

Total enrollment: 150 patients across 1 trials

NCT05479422LaborieOptilume Registry for Treatment of Stricture of the Anterior Urethra

Optilume Registry for Treatment of Stricture of the Anterior Urethra

Start: Oct 2022Est. completion: Aug 2029150 patients
N/AActive Not Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.